Zihinsel engelli ve dismorfik yüz yapısına sahip Çanakkaleli bir ailede yeni bir BRPF1 varyantına bağlı anemi ve trombositopeni: Olgu sunumu ve literatürün gözden geçirilmesi


Kose C. C., Kaya D., Akcan M. B., Silan F.

AMERICAN JOURNAL OF MEDICAL GENETICS, PART A, cilt.191, sa.6, ss.2209-2214, 2023 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Vaka Takdimi
  • Cilt numarası: 191 Sayı: 6
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1002/ajmg.a.63244
  • Dergi Adı: AMERICAN JOURNAL OF MEDICAL GENETICS, PART A
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Applied Science & Technology Source, BIOSIS, CAB Abstracts, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.2209-2214
  • Çanakkale Onsekiz Mart Üniversitesi Adresli: Evet

Özet

Intellectual developmental disorder with dysmorphic facies and ptosis (IDDDFP) (MIM#617333) is an autosomal dominant disorder characterized by delayed psychomotor development, intellectual disability (ID), and dysmorphic facial features due to pathogenic variations in the Bromodomain- and PHD Finger-Containing Protein (BRPF1) (MIM#602410) gene. Herein, we report the first Turkish patients with IDDDFP. Additionally, the patients had hematopoietic disorders such as anemia and thrombocytopenia, which have not been previously described in IDDDFP patients. Genetic testing using Whole Exome Sequencing (WES) revealed a novel heterozygous c.1433G > A; p.W478* (NM_004634.3) pathogenic variant on exon 3 of the BRPF1 gene. The patients demonstrated classical features of IDDDFP such as intellectual disability, developmental delay, ptosis, micro and retrognathia, and dysmorphic facial features, in addition to the anemia and thrombocytopenia. Apart from the variant in BRPF1, no additional genomic changes were detected by WES and chromosomal microarray analysis (CMA). Hopefully, our novel report on the hematopoietic anomalies of our patients due to BRPF1 will expand upon the clinical spectrum of IDDDFP, encourage further studies about BRPF1-hematopoietic system relations, and affect the diagnostic and therapeutic schemes of hematopoietic system disorders.